Evgeny Izumchenko to Cohort Studies
This is a "connection" page, showing publications Evgeny Izumchenko has written about Cohort Studies.
Connection Strength
0.177
-
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Ann Oncol. 2017 Oct 01; 28(10):2595-2605.
Score: 0.092
-
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFß enhance the efficacy of cancer immunotherapy. Nat Commun. 2018 02 21; 9(1):741.
Score: 0.024
-
NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis. Nat Commun. 2017 11 24; 8(1):1772.
Score: 0.023
-
An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation. Sci Rep. 2015 Aug 28; 5:13236.
Score: 0.020
-
Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. Cancer Prev Res (Phila). 2015 Mar; 8(3):208-21.
Score: 0.019